XIAP and breast cancer: Targeting XIAP both alone and in combination with LY294002 induced apoptosis in vitro and caused regression of breast cancer xenografts in vivo suggesting a role of XIAP in breast cancer tumorigenesis and at the same time, identifying XIAP as a potential therapeutic target.